Grant Pickering, CHIEF EXECUTIVE OFFICER at Vaxcyte, Inc. (PCVX), sold 29,812 shares at $75.39 ($2.3M) on 2024-06-24, disclosed to the SEC on 2024-06-25.
Scheduled sale ($2.3M) by CHIEF EXECUTIVE OFFICER under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $75.39 | 10,341 | $780K | 34.6% |
| 2 | $75.39 | 10,341 | $780K | 34.6% |
| 3 | $76.17 | 4,471 | $341K | 15.1% |
| 4 | $76.17 | 4,471 | $341K | 15.1% |
| 5 | $76.80 | 188 | $14K | 0.6% |
| Total | $75.63 avg | 29,812 |
| $2.3M |
| 100% |
| Filing → |
| PCVX | SELL | 2026-06-18 | $1.2M | — | Filing → |
| PCVX | SELL | 2024-12-10 | $401K | — | Filing → |
| PCVX | SELL | 2024-12-03 | $2.8M | — | Filing → |